Amlabu WE, Amisigo CM, Antwi CA, Awandare GA, et al. Some novel antileishmanial compounds inhibit normal cell cycle progression of Leishmania donovani promastigotes and exhibits pro-oxidative potential. PLoS One 2021;16:e0258996.
PMID: 34807936